Perflubron

Perflubron
Clinical data
ATC code V08CX01 (WHO)
Identifiers
CAS Number 423-55-2
PubChem (CID) 9873
ChemSpider 9489
UNII Q1D0Q7R4D9 YesY
ChEMBL CHEMBL1200866
ECHA InfoCard 100.006.391
Chemical and physical data
Formula C8BrF17
Molar mass 498.96 g/mol
3D model (Jmol) Interactive image
Density 1.93 g/cm3
Melting point 6 °C (43 °F)
Boiling point 142 °C (288 °F)

Perflubron (INN/USAN, or perfluorooctyl bromide; brand name Imagent) is a contrast medium for magnetic resonance imaging, computer tomography and sonography.[1] It was approved for this use in the United States by the Food and Drug Administration in 1993.[2]

Experimental research

For more information on this potential application, see Liquid breathing § Medical treatment.

Perflubron has also been tested experimentally for use in liquid breathing in premature infants with respiratory distress.[3][4]

This molecular model of Perflubron is color-coded by electron density to illustrate the positive polarisation of the large bromine atom by the inductively electron-withdrawing perfluorooctyl chain.

References

  1. Mattrey, R. F. (1989). "Perfluorooctylbromide: A new contrast agent for CT, sonography, and MR imaging". AJR. American journal of roentgenology. 152 (2): 247–252. doi:10.2214/ajr.152.2.247. PMID 2643258.
  2. FDA Approved Drug Products
  3. Wolfson, M. R.; Kechner, N. E.; Roache, R. F.; Dechadarevian, J. P.; Friss, H. E.; Rubenstein, S. D.; Shaffer, T. H. (1998). "Perfluorochemical rescue after surfactant treatment: Effect of perflubron dose and ventilatory frequency". Journal of applied physiology (Bethesda, Md. : 1985). 84 (2): 624–640. PMID 9475875.
  4. Leach, C. L.; Greenspan, J. S.; Rubenstein, S. D.; Shaffer, T. H.; Wolfson, M. R.; Jackson, J. C.; Delemos, R.; Fuhrman, B. P. (1996). "Partial Liquid Ventilation with Perflubron in Premature Infants with Severe Respiratory Distress Syndrome". New England Journal of Medicine. 335 (11): 761–767. doi:10.1056/NEJM199609123351101. PMID 8778584.


This article is issued from Wikipedia - version of the 10/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.